World

Merck Delivers Strong First Quarter

Results of Q1 2022 Group sales increase by 12.2% to € 5.2 billion; EBITDA pre up 7.8% to € 1.6 billion; EBITDA pre margin 31.3% Growth story ...

 May 13, 2022 | News

Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies an...

 May 11, 2022 | News

Merck aims to significantly reduce its greenhouse gas emissions by 2030

Merck, a leading science and technology company, aims to significantly reduce its greenhouse gas emissions by 2030. The independent Science Based Targ...

 May 10, 2022 | News

Genovac enhances its antibody discovery services with the ENPICOM IGX Platform

Genovac, a leading contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures antibodies for therapeutic, diagno...

 May 03, 2022 | News

Biopharmaceuticals: Faster to Market

To combat these challenges, biopharmaceuticals that are produced with the help of living organisms are playing an increasingly important role. However, the...

 April 21, 2022 | Opinion

Merck’s ZooMAb® Antibodies Earns First-Ever ACT Label from My Green Lab

ZooMAb® antibodies becomes the first-ever antibody to be recognized for low-environmental impact by My Green Lab ZooMAb® antibodies ra...

 April 19, 2022 | News

Agilent Joins AMBIC to Advance Biomanufacturing

Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMB...

 April 14, 2022 | News

Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza

Merck to become first company to offer a fully integrated ecosystem for advanced process technologies Brings biopharmaceutical industry closer to digita...

 April 14, 2022 | News

Jackson ImmunoResearch announces new range of detection reagents for R&D and diagnostic markets

Jackson ImmunoResearch, manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new range of detection reagents th...

 April 13, 2022 | News

Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics

 Microba Life Sciences (ASX:MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal ...

 April 05, 2022 | News

Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer

Waters Corporation (NYSE:WAT) today introduced the new Xevo™ TQ Absolute system, the most sensitive and compact benchtop tandem mass spec in its...

 March 31, 2022 | News

Boehringer Ingelheim Selects Veeva Development Cloud Worldwide to Bring Innovative Therapies to Patients Faster

Transformation focuses on reducing complexity and developing an innovative, digital culture to better understand and address unmet medical needs Boehringe...

 March 30, 2022 | News

Free Guide to Colorectal Cancer Screening from NCCN Now Available in More Than a Dozen Languages

The National Comprehensive Cancer Network® (NCCN®) today announced new translations of the recently-published NCCN Guidelines for Pa...

 March 28, 2022 | News

Innovent and Lilly Expand Strategic Partnership in Oncology

i) an agreement for Innovent to obtain the sole commercialization rights to import, market, promote, distribute and detail Cyramza® (ramucirumab) ...

 March 28, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close